encorafenib
Showing 26 - 39 of 39
BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation
Recruiting
- Metastatic Colorectal Carcinoma
- Encorafenib
- Cetuximab
-
Aschaffenburg, Germany
- +11 more
Dec 13, 2020
Malignant Melanoma Trial in Germany (Encorafenib, Binimetinib, Pembrolizumab)
Completed
- Malignant Melanoma
- Encorafenib
- +3 more
-
Freiburg, Baden-Württemberg, Germany
- +10 more
Feb 13, 2021
Metastatic Colorectal Cancer Trial in Worldwide (Encorafenib, Cetuximab, Pembrolizumab)
Recruiting
- Metastatic Colorectal Cancer
- Encorafenib
- +2 more
-
Phoenix, Arizona
- +91 more
Jan 25, 2023
Binimetinib Plus Encorafenib Real Life Investigation of Next
Recruiting
- Melanoma Stage IV
- Melanoma Stage III
- Encorafenib
- Binimetinib
-
Graz, Austria
- +58 more
Jan 15, 2021
Melanoma Trial in Worldwide (Encorafenib, Binimetinib, Pembrolizumab)
Recruiting
- Melanoma
- Encorafenib
- +2 more
-
Tucson, Arizona
- +112 more
Jul 26, 2022
Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8 Trial in United States
Recruiting
- Metastatic Colon Adenocarcinoma
- +7 more
- Cetuximab
- +2 more
-
Bloomington, Illinois
- +70 more
Aug 6, 2022
Tumors Trial in Worldwide (Encorafenib, Cetuximab, Oxaliplatin)
Recruiting
- Neoplasms
- Encorafenib
- +7 more
-
Phoenix, Arizona
- +396 more
Jan 25, 2023
Advanced Cancer, Metastatic Melanoma, Metastatic NSCLC Trial in Worldwide (LY3214996, Midazolam, Abemaciclib)
Active, not recruiting
- Advanced Cancer
- +3 more
- LY3214996
- +6 more
-
Washington, District of Columbia
- +12 more
Sep 2, 2021
Melanoma of Unknown Primary, Metastatic Malignant Tumor in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Melanoma of Unknown Primary
- +5 more
- Binimetinib
- +5 more
- (no location specified)
Feb 13, 2020
Biliary Tract Tumors Trial in Belgium, France, United Kingdom (Futibatinib, Ivosidenib, Zanidatamab)
Not yet recruiting
- Biliary Tract Neoplasms
- Futibatinib
- +9 more
-
Brussels, Belgium
- +56 more
Nov 7, 2022
BRAF V600E-mutant Metastatic Colorectal Cancer Trial in Worldwide (Encorafenib, Binimetinib, Cetuximab)
Active, not recruiting
- BRAF V600E-mutant Metastatic Colorectal Cancer
- Encorafenib
- +5 more
-
Phoenix, Arizona
- +428 more
Mar 7, 2022
Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States
Recruiting
- Acral Lentiginous Melanoma
- +6 more
- Binimetinib
- +3 more
-
Birmingham, Alabama
- +309 more
Nov 8, 2021
NSCLC Trial in Worldwide (Sasanlimab Prefilled syringe, Encorafenib, Binimetinib)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Sasanlimab Prefilled syringe
- +5 more
-
Duarte, California
- +96 more
Jan 18, 2023